Glycophos

Glycophos is a prescription‑only sodium glycerophosphate pentahydrate solution for injection, supplied in a sterile liquid form for intravenous administration. It provides inorganic phosphate to support cellular metabolism, bone mineralization, and electrolyte balance. Marketed in the European Union, Glycophos is used under medical supervision for conditions requiring phosphate supplementation.

Glycophos is indicated for clinical situations where phosphate replenishment is needed. It is commonly employed in the following contexts:

- Treatment of hypophosphatemia in hospitalized patients. - Inclusion in parenteral nutrition regimens to meet phosphate requirements. - Electrolyte replacement during major surgery or critical illness. - Support of bone mineralization in patients with prolonged phosphate deficiency. - Adjunct therapy for metabolic disorders affecting phosphate metabolism.

Side effects of Glycophos vary in frequency and severity. They are generally related to the intravenous route and phosphate load.

Common: - Mild injection site discomfort or erythema. - Transient nausea or vomiting. - Temporary elevation of serum calcium levels. - Mild headache. - Low-grade fever.

Serious: - Hyperphosphatemia leading to calcium‑phosphate precipitation. - Acute renal failure in susceptible individuals. - Severe allergic reaction or anaphylaxis. - Cardiac arrhythmias due to electrolyte imbalance. - Metabolic acidosis in high‑dose scenarios.

When prescribing Glycophos, clinicians should consider several safety measures. Important precautions include:

- Assess baseline serum phosphate, calcium, and renal function before initiation. - Adjust dose in patients with chronic kidney disease or impaired renal clearance. - Monitor electrolytes frequently during therapy to avoid hyperphosphatemia. - Use caution in patients with a history of hypersensitivity to phosphate preparations. - Avoid rapid infusion rates that may precipitate calcium‑phosphate complexes. - Discontinue if signs of severe allergic reaction develop.

Glycophos may interact with other medications or clinical conditions. Interaction considerations are:

Avoid: - Concurrent use of calcium supplements or calcium‑containing IV solutions without appropriate timing, due to risk of precipitation. - High‑dose vitamin D therapy that can increase calcium absorption.

Use with caution: - Loop diuretics, which may alter calcium and phosphate balance. - Antacids containing aluminum or magnesium, which can affect phosphate absorption. - Blood‑pressure medications that influence renal perfusion. - Drugs that affect renal function, such as aminoglycosides. - Medications that prolong QT interval, as electrolyte shifts may exacerbate arrhythmias.